prof. Filip De Vos

Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

Amber Meskens (UGent) , Sara Neyt (UGent) , Michaël Henrotte (UGent) , Jens Debacker (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2025) EMIM 2025 : European Molecular Imaging Meeting : 20th Annual Meeting of the European Society for Molecular Imaging, Abstracts.

Add to list

Conference Paper
C3
open access

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head & Neck Oncology, Abstracts.

Add to list

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Christian Vanhove (UGent) and Jens Debacker (UGent)

(2024) EANM'24 : 37th Annual Congress of the European Association of Nuclear Medicine.

Add to list

Journal Article
A2
open access

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Xiaobei Zheng, Shuai Xue, Zhongqi Zhao, Shuxin Jin, Shuhua He, Lina Jia, Zheng Li, Christian Vanhove (UGent) , Filip De Vos (UGent) , Zijun Kuang, et al.

(2024) EJNMMI RADIOPHARMACY AND CHEMISTRY. 9(1).

Add to list

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Hilde De Cock (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Lieselotte Moerman (UGent) , Christian Vanhove (UGent) , et al.

(2024) OncoPoint Symposium, 10th, Abstracts.

Add to list

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De Man (UGent) , Nick Van Laeken (UGent) , Vanessa Schelfhout (UGent) , Wolfgang P. Fendler, Bieke Lambert (UGent) , Ken Kersemans (UGent) , Sarah Piron, Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) EUROPEAN UROLOGY. 82(5). p.501-509

Add to list

Journal Article
A1
open access

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Sarah Piron, Jeroen Verhoeven (UGent) , Jan Courtyn (UGent) , Ken Kersemans (UGent) , Benedicte Descamps (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) SCIENTIFIC REPORTS. 12(1).

Add to list

Journal Article
A1
open access

Accelerated HF‐rTMS modifies SERT availability in the subgenual anterior cingulate cortex : a canine [11C]DASB study on the serotonergic system

Yangfeng Xu (UGent) , Mitchel Kappen, Kathelijne Peremans (UGent) , Dimitri De Bundel, Ann Van Eeckhout, Nick Van Laeken (UGent) , Filip De Vos (UGent) , André Dobbeleir, Jimmy Saunders (UGent) and Chris Baeken (UGent)

(2022) JOURNAL OF NUCLEAR MEDICINE. 11(6).

Add to list

Journal Article
A1
open access

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

Sarah Piron, Jeroen Verhoeven (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) NUCLEAR MEDICINE AND BIOLOGY. 106-107. p.29-51

Add to list

Journal Article
A1
open access

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Sarah Piron, Jeroen Verhoeven (UGent) , Emma De Coster (UGent) , Benedicte Descamps (UGent) , Ken Kersemans (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).

Academic Bibliography

prof. Filip De Vos

Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Accelerated HF‐rTMS modifies SERT availability in the subgenual anterior cingulate cortex : a canine [11C]DASB study on the serotonergic system

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Contents

Support

Contact